Get the content you want anytime you want.

Top 5 Contagion® News Articles for the Week of October 15, 2017


#1: HIV Cure Research Receives Financial Leg-Up from Gilead Sciences

According to a press release issued by the biopharmaceutical giant, a second round of recipients will receive financial support towards their research on a cure for HIV. A total of 5 HIV cure research initiatives will receive $7.5 million as recipients of Gilead’s HIV cure grants program.

The following individuals and their organizations and corresponding projects will receive grants to help fund their activities:
  • Alexander Marson, MD, PhD, An Integrated CRISPR Platform to Discover Regulators of HIV Latency in Primary Human T Cells, University of California, San Francisco School of Medicine, Microbiology and Immunology, Chan Zuckerberg Biohub
  • Monsef Benkirane, PhD, Paving the Way Towards Elimination of HIV Persistent CD4T Cell In Vivo, Institute of Human Genetics, French National Center for Scientific Research (CNRS) and University of Montpellier
  • Abraham L. Brass, MD, PhD, A CRISPR/Cas9 Screen to Discover HIV-1 Latency Factors, University of Massachusetts Medical School
  • Jeffrey D. Lifson, MD, TLR Ligand Augmented, Tissue Homing AIDS Virus-Specific Adoptive Cell Therapy to Target Viral Reservoirs, Frederick National Laboratory for Cancer Research, AIDS and Cancer Virus Program
  • Joseph G. Sodroski, MD, Unlocking HIV-1 Env to Deplete Viral Reservoirs, Dana-Farber Cancer Institute
Read more about the grants, here.
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.

Want more information on this topic and the opportunity to ask questions of an expert? Register for a live, ACPE accredited webinar February 28th 8-9 PM EST at this link:
Big advances in treatment can